Your session is about to expire
← Back to Search
Behavioural Intervention
Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)
N/A
Waitlist Available
Research Sponsored by Akili Interactive Labs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study day 1 to study day 42
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a video game-like therapy to help adults with ADHD improve their attention and reduce symptoms. The therapy involves playing a game designed to train the brain to focus better. The study will see if this method works for adults, whether they are on medication or not.
Eligible Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study day 1 to study day 42
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study day 1 to study day 42
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Therapeutic procedure
Secondary study objectives
Therapeutic procedure
Other study objectives
Change (Study Day 1 to Study Day 42) in Adult ADHD Quality of Life Questionnaire (AAQoL) total score
Acute Chest Syndrome
Acute Chest Syndrome
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: AKL-T01Experimental Treatment1 Intervention
Digital treatment
Find a Location
Who is running the clinical trial?
Akili Interactive Labs, Inc.Lead Sponsor
16 Previous Clinical Trials
1,859 Total Patients Enrolled
8 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
1,354 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)